Pharmaceutical innovation : incentives, competition, and cost-benefit analysis in international perspective / edited by Frank A. Sloan, Chee-Ruey Hsieh
Publication details: Cambridge ; New York : Cambridge University Press, 2007Description: xiv, 331 p. : ill. ; 24 cmISBN:- 0521874904 (hardback)
- 9780521874908 (hardback)
- QV736
| Item type | Current library | Home library | Collection | Call number | Materials specified | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|---|---|---|
| AM | PERPUSTAKAAN DR ABDUL LATIFF | PERPUSTAKAAN DR ABDUL LATIFF KOLEKSI AM-P. DR ABDUL LATIFF | - | QV736.P536 2007 9 (Browse shelf(Opens below)) | 1 | Available | 00001505364 |
Browsing PERPUSTAKAAN DR ABDUL LATIFF shelves, Shelving location: KOLEKSI AM-P. DR ABDUL LATIFF Close shelf browser (Hides shelf browser)
|
|
|
|
|
|
|
||
| QV736.M697f 2008 9 Farmakoekonomi untuk profesional kesihatan / | QV736.N972s 2007 9 Six sigma in the pharmaceutical industry : understanding, reducing, and controlling variation in pharmaceuticals and biologics / | QV736.P4845 2001 Pharmaceutical and medicines information management : principles and practice / | QV736.P536 2007 9 Pharmaceutical innovation : incentives, competition, and cost-benefit analysis in international perspective / | QV736.P537 2004 Pharmacoeconomics / | QV736.P537 2010 9 Pharmacoeconomics : from theory to practice / | QV736.P954 2002 9 Principles and practice of pharmaceutical medicine / |
Includes bibliographical references (p. 293-317) and index
Introduction / Frank A. Sloan and Chee-Ruey Hsieh -- The pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents fail: finding new drugs for the developing world / Stephen M. Maurer -- Implementing a public subsidy for vaccines / Frank A. Sloan and Charles E. Eesley -- Ensuring the future supply of vaccines: is a national vaccine authority the answer? / Frank R. Lichtenberg -- Competition between generic and branded drugs / Henry Grabowski -- The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? / Ernst R. Berndt -- Measures of costs and benefits for drugs in cost-effectiveness analysis / Mark V. Pauly -- Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience / Michael Drummond -- Pharmaceutical spending and health outcomes / Pierre-Yves Cremieux ... [et al.] -- Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan / Chee-Ruey Hsieh ... [et al.] -- Conclusions and policy implications / Frank A. Sloan and Chee-Ruey Hsieh
There are no comments on this title.